Back

Abstract: A non-canonical splicing variant in MYBPC3 leads to cryptic splicing in Hypertrophic Cardiomyopathy

5 December 2025 (14:40 - 14:50)
Organised by: Logo
Seminar Presentation Part of: Session 4 – Precision/Gene based therapy in hypertrophic cardiomyopathy OTHER Open Access ESC Cardio Genomics 2025 Council on Cardiovascular Genomics

About the speaker

Photo
Miss Marta Furtado

(Portugal)

3 More presentations in this session

Presentation thumbnail
Cardiac myosin inhibitors
Mr P. Garcia Pavia (Madrid, ES)
Slides
Presentation thumbnail
Gene therapy
Professor L. Carrier (Hamburg, DE)
Slides
Presentation thumbnail
Genotype-specific pathomechanisms and treatments
Professor J. van der Velden (Amsterdam, NL)

Access the full session

Session thumbnail
Session 4 – Precision/Gene based therapy in hypertrophic cardiomyopathy

The Event

Event poster

ESC Cardio Genomics 2025

5 December 2025 14:40 CET
You may be interested in
thumbnail
Congress Presentation
MYBPC3 genotypes associated with familial hypertrophic cardiomyopathy
11 May 2024
thumbnail
Congress Presentation
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
13 April 2024
thumbnail
Congress Presentation
Phenotypic spectrum of a Belgian pathogenic founder variant in MYBPC3
21 May 2023
thumbnail
Congress Presentation
Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes in over 200,000 adults
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources